Truist Financial Corp Sells 12,321 Shares of Danaher Co. (NYSE:DHR)

Truist Financial Corp decreased its stake in shares of Danaher Co. (NYSE:DHR - Free Report) by 3.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 380,121 shares of the conglomerate's stock after selling 12,321 shares during the period. Truist Financial Corp owned about 0.05% of Danaher worth $87,257,000 at the end of the most recent quarter.

Several other institutional investors have also bought and sold shares of DHR. FMR LLC boosted its holdings in Danaher by 15.8% during the 3rd quarter. FMR LLC now owns 23,617,424 shares of the conglomerate's stock worth $6,566,116,000 after acquiring an additional 3,217,631 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in Danaher by 3.0% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 5,097,986 shares of the conglomerate's stock worth $1,417,342,000 after purchasing an additional 148,251 shares during the last quarter. Fisher Asset Management LLC grew its position in Danaher by 2.6% in the 3rd quarter. Fisher Asset Management LLC now owns 4,552,640 shares of the conglomerate's stock worth $1,265,725,000 after purchasing an additional 116,299 shares in the last quarter. Massachusetts Financial Services Co. MA increased its stake in Danaher by 17.6% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 3,582,982 shares of the conglomerate's stock valued at $996,141,000 after buying an additional 535,254 shares during the last quarter. Finally, Montrusco Bolton Investments Inc. lifted its position in shares of Danaher by 0.6% during the 4th quarter. Montrusco Bolton Investments Inc. now owns 1,715,826 shares of the conglomerate's stock worth $382,936,000 after buying an additional 9,942 shares in the last quarter. Institutional investors own 79.05% of the company's stock.

Analysts Set New Price Targets

Several research firms have recently issued reports on DHR. Jefferies Financial Group reduced their target price on Danaher from $285.00 to $260.00 and set a "buy" rating for the company in a report on Wednesday, January 29th. Citigroup reduced their price objective on Danaher from $285.00 to $265.00 and set a "buy" rating for the company in a research note on Thursday, January 30th. Barclays lowered their target price on Danaher from $275.00 to $240.00 and set an "equal weight" rating on the stock in a research note on Thursday, January 30th. JPMorgan Chase & Co. reduced their price target on shares of Danaher from $310.00 to $300.00 and set an "overweight" rating for the company in a research report on Tuesday, January 28th. Finally, Raymond James reaffirmed a "market perform" rating on shares of Danaher in a research report on Monday, February 3rd. Seven investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $278.00.

Danaher Stock Performance

Shares of NYSE:DHR traded up $1.91 during midday trading on Friday, reaching $209.86. 6,209,935 shares of the company traded hands, compared to its average volume of 4,574,762. Danaher Co. has a 12 month low of $196.80 and a 12 month high of $281.70. The firm's fifty day moving average price is $226.71 and its two-hundred day moving average price is $247.11. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. The firm has a market capitalization of $151.58 billion, a price-to-earnings ratio of 39.75, a price-to-earnings-growth ratio of 2.61 and a beta of 0.83.

Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, meeting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same quarter in the previous year, the firm earned $2.09 EPS. On average, equities analysts expect that Danaher Co. will post 7.67 earnings per share for the current year.

Danaher Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be issued a $0.32 dividend. This represents a $1.28 annualized dividend and a yield of 0.61%. This is an increase from Danaher's previous quarterly dividend of $0.27. Danaher's dividend payout ratio (DPR) is presently 20.45%.

Insider Activity

In related news, SVP Brian W. Ellis sold 5,700 shares of Danaher stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the sale, the senior vice president now owns 20,230 shares of the company's stock, valued at approximately $4,534,149.90. This trade represents a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 11.10% of the company's stock.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.